A panel of experts from the US Food and Drug Administration (FDA) voted on Tuesday (10/26) to approve the Pfizer/BioNTech coronavirus vaccine for use in children ages 5 to 11.
The recommendations of this committee are only advisory, but it is rare that they are not accepted by the FDA.
If the vaccine is approved for this age group, approximately 28 million children will be eligible to be vaccinated in the United States.
It is recalled that, a few days ago, the White House announced its plan to start vaccinating 28,000,000 children between the ages of 5 and 11 against the coronavirus starting next month, with the Pfizer/BioNTech vaccine.
A CDC expert panel is expected to meet on the issue on November 2-3, with the Authority’s recommendation expected to be issued very soon after that date.
The vaccines will be available in pediatricians’ offices, in pediatric hospitals, but also in schools, the White House clarified. Their packaging has been modified, to make them easier to use than these structures, into packs of ten vials (each containing ten doses).
The government will also distribute necessary equipment, including smaller needles, while ensuring that the US has procured enough doses to vaccinate all children in this age group.
source: iefi merida